Promus Capital, LLC Zoetis Inc. Transaction History
Promus Capital, LLC
- $157 Billion
- Q3 2025
A detailed history of Promus Capital, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Promus Capital, LLC holds 4,385 shares of ZTS stock, worth $520,938. This represents 0.41% of its overall portfolio holdings.
Number of Shares
4,385
Previous 4,364
0.48%
Holding current value
$520,938
Previous $681 Million
5.72%
% of portfolio
0.41%
Previous 0.44%
Shares
7 transactions
Others Institutions Holding ZTS
# of Institutions
2,086Shares Held
424MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...